
    
      An open label, balanced, randomized, two-treatment, two-period, two-sequence, single dose,
      crossover, oral bioequivalence study of moxifloxacin tablets 400 mg of Dr. Reddy's
      Laboratories Limited, comparing with Avelox Â® Tablets 400 mg of Bayer Healthcare
      Pharmaceuticals Inc. in healthy, adult, human subjects under fasting conditions.
    
  